Here we present an overview of recent advancements in AI applications across the entire drug development workflow, encompassing the identification of disease targets, drug discovery, …

2025年1月20日 · This Review explores the state-of-the-art applications of artificial intelligence in small-molecule drug development, from target identification and drug synthesis up to clinical …

Here we present an overview of recent advancements in AI applications across the entire drug development workflow, encompassing the identification of disease targets, drug discovery,...

Lifeng Kang is a Senior Lecturer at the School of Pharmacy, Faculty of Medicine and Health, University of Sydney. His laboratory is focused on microscale technologies and 3D printing for …

‪Associate Professor, School of Pharmacy, Faculty of Medicine and Health, University of Sydney‬ - ‪‪Cited by 4,423‬‬ - ‪drug delivery‬ - ‪regenerative medicine‬ - ‪3D printing.‬ -...

2025年1月1日 · Deep Multiple Instance Learning is introduced in drug repositioning for the first time. Meta-path instances is elaborately designed and efficiently represented in proposed …

Current antiviral drug discovery efforts face many challenges, including development of new drugs during an outbreak and coping with drug resistance due to rapidly accumulating viral...

Small-molecule drugs are organic compounds affecting molecular pathways by targeting important proteins. These compounds have a low molecular weight, making them penetrate …

2025年1月13日 · Kang et al. 42 (2022) utilized ProtBert, a BERT-based pre-trained model for amino acids, and RoBERTa pre-trained for encoding drug SMILES format, significantly …